Class 4 Medicines Defect Information: GlaxoSmithKline UK Ltd

GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is inside the sealed pack, and contains unapproved text.

Related Keywords

United Kingdom , London , City Of , , Glaxosmithkline United Kingdom Ltd , United Kingdom Ltd , United Kingdom Ltd Medical Information Department , Defective Medicines Report Centre , Pharmaceutical Ingredient , Smithkline United Kingdom Ltd , Product Characteristics , Patient Information Leaflet , Package Leaflet , Electronic Medicines Compendium , Kingdom Ltd , Direct Healthcare Professional , Patient Information , Kingdom Ltd Medical Information Department , Medicines Notification ,